More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$162.27B
EPS
0.7
P/E ratio
37.2
Price to sales
2.53
Dividend yield
6.041%
Beta
0.306826
Previous close
$28.86
Today's open
$28.48
Day's range
$28.35 - $28.67
52 week range
$23.62 - $31.44
show more
CEO
Albert Bourla
Employees
75000
Headquarters
New York, NY
Exchange
New York Stock Exchange
Shares outstanding
5.70B
Issue type
Common Stock
Healthcare
Pharmaceuticals
Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics. Under the agreement, Pfizer obtains exclusive rights outside Greater China to develop, manufacture and commercialize three pre-IND in vivo chimeric antigen receptor T-cell (CAR-T) programs that are focused on treating autoimmune diseases. Pfizer also receives ri.
Business Wire • 14 hours ago

3 High-Yield Dividend Stocks Down Nearly 30% or More in 5 Years
Three famous dividend payers have lost a big chunk of their value since 2020, and two already slashed their payouts. Before chasing the fat yields, income investors should ask which of these beaten-down stocks still has a dividend worth trusting.
24/7 Wall Street • 12 hours ago

Pfizer: Strong Growth Momentum And Attractive Valuation Support A Strong Buy
Pfizer remains a Strong Buy: improved gross margin, accelerating launched and acquired products, and raised guidance support the thesis. Q3 revenue reached $16.58B, beating by $700M; launched and acquired products grew 32%, while gross margin improved to about 77%. PFE raised FY26 revenue guidance to $62B–$64B and adjusted EPS guidance to $2.95–$3.05; implied Q4 expectations still look conservative.
Seeking Alpha • 19 hours ago

Pfizer: The Patent Cliff Fears Are Overblown
Pfizer Inc., a Big Pharma player offering a 5.96% dividend yield, remains a controversial choice among long-term retail investors. Most concerns reflect PFE's upcoming patent expiration cycle, which is expected to last about 3 years. However, I believe these fears are overblown given PFE's oncology portfolio, Eliquis, and tafamidis franchise, which delivered strong Q3 performance.
Seeking Alpha • 11 hours ago

Pfizer CEO Sees Growth Beyond Patent Cliff, Highlights Monthly Obesity Drug Ambitions
Pfizer NYSE: PFE expects recently launched medicines and a growing pipeline to help it emerge from a period of patent expirations with high single-digit growth, CEO Albert Bourla said at the Jefferies London Healthcare Conference.
MarketBeat • Nov 17, 2026

Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Nov 17, 2026

5 Huge Dividend Payers the IRS Leaves Alone Inside a Roth
Two investors can own the same five blue chip dividend stocks and keep different amounts of income. When held outside a tax-advantaged account, every payment is taxed the year it arrives.
24/7 Wall Street • Nov 17, 2026

5 “Forever Income” Dividend Stocks Yielding 5% and More for Boomers
If you're retired and living off a portfolio, a dividend has two jobs. It has to pay enough to matter, and it has to keep paying through a full market cycle.
24/7 Wall Street • Nov 17, 2026

5 Safe High-Yield Dividend Stocks Boomers Should Buy Before Year-End
Retirees heading into year-end need income that holds up through a recession, a rate shift or a bad quarter, so a high yield alone isn't enough. These five US-listed payers come from five different sectors (telecom, real estate, asset management, pharma and tobacco).
24/7 Wall Street • Nov 17, 2026

Wall Street Forgot These 3 Dividend Stocks — Now They Pay Over 5%
Income investors tend to crowd into whatever is popular, leaving solid payers ignored. The three stocks below are in health care, telecom, and financials.
24/7 Wall Street • Nov 17, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Pfizer Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.